Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
Category: Top Headlines · Source: CNBC World · Published: 2026-03-27 11:43:54
The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to work faster and better than anything currently on the market.
Open canonical link
Sources